In focus · trending topic

congenital hyperinsulinism

8 stories · following the connections

XOMA Announces up to $22 Million Generated from Sale of Royalty Streams from Two License Agreements to HealthCare Royalty Partners and Provides Corporate Update

By Nasdaq OMXDec 21, 2016, 10:00 PM UTC

XOMA Reports Third Quarter 2016 Achievements and Financial Results

By Nasdaq OMXNov 9, 2016, 2:00 PM UTC

XOMA Announces Significant Step Toward Initiating Pediatric Phase 2 Clinical Study for XOMA 358 in Children with Congenital Hyperinsulinism

By Nasdaq OMXOct 19, 2016, 1:01 PM UTC

XOMA Provides Update from Ongoing Phase 2 XOMA 358 Clinical Studies

By Nasdaq OMXSep 15, 2016, 11:26 PM UTC

XOMA to Host XOMA 358 Clinical Update Webcast and Conference Call on September 15, 2016

By Nasdaq OMXSep 6, 2016, 1:00 PM UTC

XOMA Reports Fourth Quarter and Full-Year 2015 Financial Results

By Nasdaq OMXMar 9, 2016, 9:01 PM UTC

XOMA to Present at the Cowen & Company Health Care Conference

By Nasdaq OMXMar 2, 2016, 6:30 PM UTC

XOMA to Announce Fourth Quarter and Full Year 2015 Financial Results and Host Webcast on March 9

By Nasdaq OMXFeb 24, 2016, 6:29 PM UTC